Robert J. Bitterman

Form D signer

Robert J. Bitterman

President at Phio Pharmaceuticals

Form D signer

Capital raised by Phio Pharmaceuticals

$2.3M+$1.4M latest round

5 Form D filings · first filed Jan 2025 · Marlborough, MA

CURRENT ROLE: President
SECTOR: Biotech
COMPANY FILINGS: 5
TEAM ON FILE: 3
FOUNDED: —
30D INTEREST: 1 ↗

Career

1 company on file

Phio PharmaceuticalsBiotech · Marlborough, MAsince Jan 2025

President

Signatory on Phio Pharmaceuticals's Form D filings · $2.3M raised across 5

Company filings

via EDGAR · Form D for Phio Pharmaceuticals5

DateCompanyFormAmountRole on filing

Nov 4, 2025Phio PharmaceuticalsForm D+$1.4MPresident

Form DNov 4, 2025 · Phio Pharmaceuticals+$1.4Mas President

Jul 28, 2025Phio PharmaceuticalsForm D+$232KPresident

Form DJul 28, 2025 · Phio Pharmaceuticals+$232Kas President

Jan 17, 2025Phio PharmaceuticalsForm D+$153KPresident

Form DJan 17, 2025 · Phio Pharmaceuticals+$153Kas President

Jan 15, 2025Phio PharmaceuticalsForm D+$208KPresident

Form DJan 15, 2025 · Phio Pharmaceuticals+$208Kas President

Jan 14, 2025Phio PharmaceuticalsForm D+$266KPresident

Form DJan 14, 2025 · Phio Pharmaceuticals+$266Kas President

Overview

Last filing Nov 4, 2025

Robert J. Bitterman is on file as President at Phio Pharmaceuticals in Marlborough, MA. Phio Pharmaceuticals has 5 Form D filings on record, $2.3M raised in total. Robert J. Bitterman appears as a signatory on the company's filings.

Teammates

Phio Pharmaceuticals · 2

David DemingDirector Lisa CarsonExecutive Officer

Products

Phio Pharmaceuticals · 1

PH-762Cancer immunotherapeutic

PH-762 is the flagship product candidate of Phio Pharmaceuticals, currently in clinical studies. It shows promising potential in enhancing cancer treatment by modulating immune responses to improve therapy outcomes.